Login to Your Account



Pharma: Other News To Note


Tuesday, March 20, 2012
• Watson Pharmaceuticals Inc., of Parsippany, N.J., said its subsidiary filed an abbreviated new drug application seeking approval to market Niacin extended-release tablets, generic versions of Niaspan from Abbott, of Abbott Park, Ill.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription